JENNIFER EPPERSON: Open Payments
NPI 1528400710 · INDEPENDENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 80 payments from 20 companies in 2025. Trend: 2023 $915 · 2024 $999 · 2025 $1,912
Food & beverage: $1,912
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $669 |
| Vanda Pharmaceuticals Inc. | 11 | $234 |
| AstraZeneca Pharmaceuticals LP | 2 | $217 |
| Novo Nordisk Inc | 6 | $129 |
| Amgen Inc. | 6 | $103 |
| Lilly USA, LLC | 6 | $96 |
| PFIZER INC. | 5 | $84 |
| Astellas Pharma US Inc | 3 | $80 |
| Dexcom, Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: VRAYLAR, UBRELVY, HETLIOZ, AIRSUPRA, BREZTRI, Veozah, Wegovy, MOUNJARO.
Industry payments across KY — which companies pay providers there.
